DEVOURED
Ozempic and Other GLP-1s Are Being Linked to Fewer Serious Infections—Including TB
GLP-1 drugs like Ozempic show promise in reducing severe infections in vulnerable patient populations, including those with type 2 diabetes.
What: Recent medical studies suggest that GLP-1 receptor agonists, primarily used for weight management and diabetes, may provide secondary health benefits by lowering the risk or severity of infections such as tuberculosis.
Decoder
- GLP-1: Glucagon-like peptide-1 agonists, a class of medication used to treat type 2 diabetes and obesity by mimicking a hormone that regulates appetite and blood sugar.
Original article
Recent studies have suggested that GLP-1 drugs can reduce the occurrence or severity of certain infections, particularly among more vulnerable groups like people with type 2 diabetes.
Explore all 57 articles in today's digest
Fresh dev news, AI-digested daily. Never miss a trend at devoured.fyi